Status: Recruiting
Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
This is a Phase 3 clinical study to evaluate the efficacy, safety, and tolerability of boric acid 600 mg vaginal inserts in patients with VVC.
Participants needed: 400
Trial details
Phase: Phase 3Age: 12+Biological sex: FemaleType: InterventionalSponsor: pH-D Feminine Health LLCUpdated: Jun 3, 2026Locations: 27
Eligibility criteria
Patients who are postmenarcheal, nonpregnant biological females, 12 years of age... [+19]
Patients with known or suspected other active infectious causes of cervicitis, v... [+28]